Peer Reviewed
Feature Article Dermatology
An approach to management of morphoea
Abstract
Reassurance and counselling for patients with morphoea may be sufficient as morphoea often resolves with time. It should, however, be differentiated from systemic sclerosis, which is a far more serious disease.
Key Points
- Morphoea is a benign dermatosis that has a good long-term prognosis.
- Diagnostic tests are not usually necessary for morphoea but it needs to be differentiated from systemic sclerosis, with which it is often confused.
- Small morphoeic plaques can be monitored without active treatment.
- Topical agents can be used in the early inflammatory stage.
- Reassurance of patients is the key to preventing needless worry.
Purchase the PDF version of this article
Already a subscriber? Login here.